Skip to content

The survey about preferences for treatment of patients with Parkinson's disease

Treatment preferences of patients with Parkinson's disease: a cross-sectional observational study - Treatment preferences of patients with Parkinson's disease: a cross-sectional observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000053326
Enrollment
300
Registered
2024-01-12
Start date
2024-01-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson&#39

Interventions

None listed

Sponsors

Eisai Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with a diagnosis of Parkinson's disease 2. Patients received treatments with anti-Parkinson's drugs when participating in the study 3. Patients being able to answer the online survey 4. Patients who consent to the study spring from their own free will

Exclusion criteria

Exclusion criteria: 1. Patients being unable to answer the survey themselves or without someone who manipulates instead of patients

Design outcomes

Primary

MeasureTime frame
The relative importance of attribute and preference weights of levels for anti-Parkinson's drugs

Secondary

MeasureTime frame
The subgroup analysis of primary outcomes

Countries

Japan

Contacts

Public ContactYuki Kogo

Eisai Co., Ltd. Medical Headquarters

y2-kogo@hhc.eisai.co.jp070-7536-2322

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026